Sepsis Anemia Erythropoietin Sepsis Survival rate
Conditions
Interventions
Sepsis patients who received erythropoietin,Sepsis patients who did not received erythropoietin
Treatment,Treatment
EPO group,non-
Sponsors
None
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1.Participants who admitted to intensive care unit due to sepsis/ septic shock. 2.Participants who age of 18 years or older with received erythropoietin according to their underlying disease.
Exclusion criteria
Exclusion criteria: 1. Participants with missing clinical and laboratory data. 2. Participants who have been referred to another hospital. 3. Participants who have been treated with alternate to standard sepsis bundle scheme for sepsis and/or septic shock treatment as described in sepsis management guidelines.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Survival rate 29 days Kaplan-Meier Analysis | — |
Secondary
| Measure | Time frame |
|---|---|
| The total dose of inotropic drugs requirement (cumulative dose) during septic shock, adverse effects 29 days Vasopressor dependency index ,Percentage of patients receiving red-cell transfusion During day 1-29 Number of patients receiving red-cell / total number of patients in the study arm.,Change of hemoglobin concentration from baseline During day 1-29 Hb at day 29 - Hb at day 1,Adverse effects from EPO treatment During day 1-29 Reported symptoms | — |
Countries
Thailand
Contacts
Public ContactWiwat Chancharoenthana
Outcome results
None listed